Market Size of Brazil Respiratory Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.70 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Brazil Respiratory Devices Market Analysis
The Brazil respiratory devices market is expected to register a CAGR of 7.7% over the forecast period. Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus primarily affects the respiratory system of the body, it had a severe impact on those who had lung comorbidities, which had an impact on the market under study.
- According to the report published by IHME, in October 2022, in Brazil, the daily infections of COVID-19 are still increasing week by week, and the daily estimated COVID-19 infections in the reference scenario will rise to 1,012,550 by January 25, 2023, and in the 80% mask use scenario will rise to 961,430 by February 1, 2023. Hence the demand for proper respiratory diagnosis and management devices increases which may significantly impact the market to grow over the coming years.
- The major factors attributing to the growth of the Brazilian respiratory devices market are the increasing prevalence of chronic obstructive pulmonary disease patients (COPD), tuberculosis, asthma, and sleep apnea, along with technological advancements and increasing applications in homecare settings remain the major drivers in the country.
- In Brazil, chronic diseases, including chronic obstructive pulmonary disease (COPD), and tuberculosis, occupy the leading positions in morbidity and mortality. Smoking is also contributing to the growth of the respiratory devices market. As per the report published by J Bras Pneumol in April 2022, multidrug-resistant tuberculosis increases lung damage. Hence the study was conducted in a Brazilian cohort using the spirometry and MasterScreen Body-PFT device and stated that patients should be examined soon after finishing tuberculosis treatment, and if post-tuberculosis lung illness is discovered, it should be addressed and pulmonary rehabilitation should be provided because there is evidence that it is beneficial for patients. Thus the new advancements in the detection of respiratory diseases increase the demand for respiratory devices that driving the market growth over the study period.
- However, the high cost of respiratory devices may restrain market growth over the forecast period.
